Bison Wealth LLC Boosts Stake in Colgate-Palmolive (NYSE:CL)

Bison Wealth LLC lifted its holdings in Colgate-Palmolive (NYSE:CL) by 5.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,756 shares of the company’s stock after purchasing an additional 290 shares during the quarter. Bison Wealth LLC’s holdings in Colgate-Palmolive were worth $459,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently modified their holdings of CL. Dimensional Fund Advisors LP grew its holdings in shares of Colgate-Palmolive by 4.0% in the first quarter. Dimensional Fund Advisors LP now owns 2,444,508 shares of the company’s stock worth $185,376,000 after acquiring an additional 94,837 shares during the period. Covestor Ltd grew its holdings in shares of Colgate-Palmolive by 71.9% in the first quarter. Covestor Ltd now owns 2,451 shares of the company’s stock worth $186,000 after acquiring an additional 1,025 shares during the period. Mackenzie Financial Corp grew its holdings in shares of Colgate-Palmolive by 8.5% in the first quarter. Mackenzie Financial Corp now owns 1,882,813 shares of the company’s stock worth $142,774,000 after acquiring an additional 146,936 shares during the period. First Western Trust Bank bought a new stake in shares of Colgate-Palmolive in the first quarter worth $569,000. Finally, Wsfs Capital Management LLC bought a new stake in shares of Colgate-Palmolive in the first quarter worth $288,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on CL. Wells Fargo & Company lifted their price objective on Colgate-Palmolive from $80.00 to $88.00 and gave the stock an “equal weight” rating in a report on Monday, January 29th. TheStreet raised Colgate-Palmolive from a “c+” rating to a “b+” rating in a report on Friday, January 26th. Evercore ISI boosted their price target on Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a report on Monday, April 8th. JPMorgan Chase & Co. boosted their price target on Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a report on Thursday, January 18th. Finally, Barclays boosted their price target on Colgate-Palmolive from $82.00 to $84.00 and gave the company an “equal weight” rating in a report on Friday, April 12th. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average target price of $89.50.

Insider Buying and Selling

In related news, CEO Noel R. Wallace sold 29,772 shares of the business’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $84.06, for a total value of $2,502,634.32. Following the sale, the chief executive officer now directly owns 301,343 shares in the company, valued at $25,330,892.58. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, CEO Noel R. Wallace sold 69,948 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total value of $5,891,020.56. Following the completion of the sale, the chief executive officer now directly owns 286,881 shares of the company’s stock, valued at approximately $24,161,117.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Noel R. Wallace sold 29,772 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $84.06, for a total value of $2,502,634.32. Following the completion of the sale, the chief executive officer now directly owns 301,343 shares of the company’s stock, valued at $25,330,892.58. The disclosure for this sale can be found here. Over the last three months, insiders have sold 232,371 shares of company stock worth $19,505,099. Corporate insiders own 0.37% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $86.16 on Wednesday. The company has a quick ratio of 0.71, a current ratio of 1.11 and a debt-to-equity ratio of 8.59. The company has a market capitalization of $70.82 billion, a price-to-earnings ratio of 30.99, a PEG ratio of 3.26 and a beta of 0.42. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $90.37. The stock’s 50-day simple moving average is $86.92 and its 200-day simple moving average is $80.58.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. The company had revenue of $4.95 billion for the quarter, compared to the consensus estimate of $4.89 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The firm’s revenue for the quarter was up 6.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.77 earnings per share. As a group, analysts expect that Colgate-Palmolive will post 3.49 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be given a $0.50 dividend. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.32%. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s payout ratio is currently 69.06%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.